Foto 1 di 3



Galleria
Foto 1 di 3



Ne hai uno da vendere?
Handbook Diagnosis Treatment of Bipolar Disorders Psychiatry Ketter New SEALED
US $39,95
CircaEUR 34,48
o Proposta d'acquisto
Condizione:
Nuovo
Libro nuovo, intatto e non letto, in perfette condizioni, senza pagine mancanti o danneggiate. Per maggiori dettagli, consulta l'inserzione del venditore.
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Spedizione:
US $7,47 (circa EUR 6,45) USPS Media MailTM.
Oggetto che si trova a: Westdale, New York, Stati Uniti
Consegna:
Consegna prevista tra il gio 7 ago e il mar 12 ago
Restituzioni:
Restituzioni non accettate.
Pagamenti:
Fai shopping in tutta sicurezza
Il venditore si assume la piena responsabilità della messa in vendita dell'oggetto.
Numero oggetto eBay:146591451342
Specifiche dell'oggetto
- Condizione
- Book Title
- bipolar disorder
- Genre
- Psychiatry
- Topic
- Treatments
- ISBN
- 9781585623136
Informazioni su questo prodotto
Product Identifiers
Publisher
American Psychiatric Association Publishing
ISBN-10
158562313X
ISBN-13
9781585623136
eBay Product ID (ePID)
15038668698
Product Key Features
Number of Pages
768 Pages
Publication Name
Handbook of Diagnosis and Treatment of Bipolar Disorders
Language
English
Publication Year
2009
Subject
Psychiatry / Psychopharmacology, Psychiatry / General, Psychopathology / Bipolar Disorder
Type
Textbook
Subject Area
Psychology, Medical
Format
Trade Paperback
Dimensions
Item Height
1.8 in
Item Weight
43 Oz
Item Length
9 in
Item Width
6 in
Additional Product Features
Intended Audience
Scholarly & Professional
LCCN
2009-011729
Reviews
"This "handbook" is a true tour de force for clinicians who want to acquire and/or improve their skills in the diagnosis and management of patients with bipolar disorder."- Robert M. A. Hirschfeld, M.D., The Journal of Clinical Psychiatry , June 2011, "Treatment of bipolar disorders is both complex and rapidly changing. Management strategies often reflect a mix of clinical experience and evidence-based literature. This manual comprehensively distills the vast amount of literature examining the efficacy, safety, tolerability, pharmacokinetics, illness phase-specific dosing, and drug interactions of medications used to treat the various aspects of bipolar illness. It presents the information in a clinically relevant, wonderfully organized manner. I highly recommend this to any practitioner who provides care for individuals with bipolar illness."- Heather Huang, M.D., Doody Enterprises , 2010, "Dr. Ketter and his colleagues have provided for us a timely clinical guide for one of our most disabling disorders, namely bipolar disorder. A wonderful mix of evidence-based and clinical expertise, this clinical manual sets a new standard for assessment and management manuals for psychiatric disorders. Since the field is rapidly advancing, I will look forward already to the next edition."- David J. Kupfer, M.D., Professor and Chair, Department of Psychiatry, University of Pittsburgh School of Medicine, This "handbook" is a true tour de force for clinicians who want to acquire and/or improve their skills in the diagnosis and management of patients with bipolar disorder., "This is a treasure trove of information and guidance for anyone who treats individuals with bipolar disorder or who wants to learn to do so. The authors succeed in their goal of attempting to provide clinicians with the empirical data needed to balance benefit and risk. I'd like to have two copies of this valuable collection of chapters: one for the office as a guide to treatment and one for home as a reference to the rapidly growing literature on the treatment of bipolar disorder."- Ellen Frank, Ph.D., Distinguished Professor of Psychiatry, University of Pittsburgh School of Medicine
Dewey Edition
22
Grade From
College Graduate Student
Illustrated
Yes
Dewey Decimal
616.89/5
Table Of Content
ContributorsPrefaceChapter 1. Principles of Assessment and Treatment of Bipolar DisordersChapter 2. DSM-IV-TR Diagnosis of Bipolar DisordersChapter 3. Addressing Clinical Diagnostic Challenges in Bipolar DisordersChapter 4. Multiphase Treatment Strategy for Bipolar DisordersChapter 5. Overview of Pharmacotherapy for Bipolar DisordersChapter 6. Management of Acute Manic and Mixed Episodes in Bipolar DisordersChapter 7. Management of Acute Major Depressive Episodes in Bipolar DisordersChapter 8. Longer-Term Management of Bipolar DisordersChapter 9. Management of Rapid-Cycling Bipolar DisordersChapter 10. Management of Bipolar Disorders in Children and AdolescentsChapter 11. Management of Bipolar Disorders in WomenChapter 12. Management of Bipolar Disorders in Older AdultsChapter 13. Mood Stabilizers and Antipsychotics: Pharmacokinetics, Drug Interactions, Adverse Effects, and Administration Chapter 14. Antidepressants, Anxiolytics/Hypnotics, and Other Medications: Pharmacokinetics, Drug Interactions, Adverse Effects, and AdministrationChapter 15. Adjunctive Psychosocial Interventions in the Management of Bipolar DisordersAppendices:A. Florida Best Practice Medication Guidelines for Bipolar DisorderB. Quick Reference Medication FactsC. Quick Reference Resources and ReadingsIndex
Synopsis
This readable guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. Handbook of Diagnosis and Treatment of Bipolar Disorders emphasizes recent controlled studies and FDA-approved indications and translates these data into the real world of clinical practice. The contributions of the eleven chapter authors from Stanford University reflect more than a decade of clinical research and treatment undertaken at that institution, including advances in diagnosis and interventions supported by controlled studies. They provide crucial information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations -- such as children, women, and older adults -- and patients with particular challenging illness course such as rapid cycling. This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. It describes all FDA-approved indications -- reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase-specific dosing, and drug interactions. A chapter on multiphase treatment strategy explains crucial illness transition points and describes how these have been integrated with knowledge of illness phase in mood disorders. The book then demonstrates the relevance of this approach to therapeutics by providing: An overview of pharmacotherapy that covers the emergence of evidence-based pharmacotherapy and number-needed-to-treat and -harm analyses. Guidelines to managing acute manic and mixed episodes that include evidence-based assessments of lithium, divalproex, carbamazepine, and second-generation antipsychotics. Coverage of acute major depressive episodes in bipolar disorders that outlines four tiers of treatment for this most pervasive illness phase with the fewest approved treatments. Discussion of the longer-term management of bipolar disorders, including reviews of controlled trials of recently approved pharmacotherapies such as lamotrigine, olanzapine, aripiprazole, and adjunctive quetiapine. A review of the use of mood stabilizers and second-generation antipsychotics, often in combinations, as well as the controversial role of adjunctive antidepressants in treating patients with rapid-cycling bipolar disorders. Description of important advances in evidence-based adjunctive psychotherapeutic interventions in bipolar depression, and bipolar maintenance treatment. Comprehensive in scope, yet readily accessible for application to clinical practice, the book includes summary tables, quick-reference lists of clinical pearls, and case studies to make its content more relevant. Handbook of Diagnosis and Treatment of Bipolar Disorders is the ideal source for integrating recent research into everyday practice., This guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. This book emphasizes recent controlled studies and FDA-approved indications and translates these data into the real world of clinical practice., This readable guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. Handbook of Diagnosis and Treatment of Bipolar Disorders emphasizes recent controlled studies and FDA-approved indications and translates these data into the real world of clinical practice. The contributions of the eleven chapter authors from Stanford University reflect more than a decade of clinical research and treatment undertaken at that institution, including advances in diagnosis and interventions supported by controlled studies. They provide crucial information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations--such as children, women, and older adults--and patients with particular challenging illness course such as rapid cycling. This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. It describes all FDA-approved indications--reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase-specific dosing, and drug interactions. A chapter on multiphase treatment strategy explains crucial illness transition points and describes how these have been integrated with knowledge of illness phase in mood disorders. The book then demonstrates the relevance of this approach to therapeutics by providing: * An overview of pharmacotherapy that covers the emergence of evidence-based pharmacotherapy and number-needed-to-treat and -harm analyses.* Guidelines to managing acute manic and mixed episodes that include evidence-based assessments of lithium, divalproex, carbamazepine, and second-generation antipsychotics.* Coverage of acute major depressive episodes in bipolar disorders that outlines four tiers of treatment for this most pervasive illness phase with the fewest approved treatments.* Discussion of the longer-term management of bipolar disorders, including reviews of controlled trials of recently approved pharmacotherapies such as lamotrigine, olanzapine, aripiprazole, and adjunctive quetiapine. * A review of the use of mood stabilizers and second-generation antipsychotics, often in combinations, as well as the controversial role of adjunctive antidepressants in treating patients with rapid-cycling bipolar disorders. * Description of important advances in evidence-based adjunctive psychotherapeutic interventions in bipolar depression, and bipolar maintenance treatment. Comprehensive in scope, yet readily accessible for application to clinical practice, the book includes summary tables, quick-reference lists of clinical pearls, and case studies to make its content more relevant. Handbook of Diagnosis and Treatment of Bipolar Disorders is the ideal source for integrating recent research into everyday practice., This readable guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. Handbook of Diagnosis and Treatment of Bipolar Disorders emphasizes recent controlled studies and FDA-approved indications and translates these data into the real world of clinical practice. The contributions of the eleven chapter authors from Stanford University reflect more than a decade of clinical research and treatment undertaken at that institution, including advances in diagnosis and interventions supported by controlled studies. They provide crucial information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations -- such as children, women, and older adults -- and patients with particular challenging illness course such as rapid cycling. This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. It describes all FDA-approved indications -- reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase-specific dosing, and drug interactions. A chapter on multiphase treatment strategy explains crucial illness transition points and describes how these have been integrated with knowledge of illness phase in mood disorders. The book then demonstrates the relevance of this approach to therapeutics by providing: - An overview of pharmacotherapy that covers the emergence of evidence-based pharmacotherapy and number-needed-to-treat and -harm analyses.- Guidelines to managing acute manic and mixed episodes that include evidence-based assessments of lithium, divalproex, carbamazepine, and second-generation antipsychotics.- Coverage of acute major depressive episodes in bipolar disorders that outlines four tiers of treatment for this most pervasive illness phase with the fewest approved treatments.- Discussion of the longer-term management of bipolar disorders, including reviews of controlled trials of recently approved pharmacotherapies such as lamotrigine, olanzapine, aripiprazole, and adjunctive quetiapine. - A review of the use of mood stabilizers and second-generation antipsychotics, often in combinations, as well as the controversial role of adjunctive antidepressants in treating patients with rapid-cycling bipolar disorders. - Description of important advances in evidence-based adjunctive psychotherapeutic interventions in bipolar depression, and bipolar maintenance treatment. Comprehensive in scope, yet readily accessible for application to clinical practice, the book includes summary tables, quick-reference lists of clinical pearls, and case studies to make its content more relevant. Handbook of Diagnosis and Treatment of Bipolar Disorders is the ideal source for integrating recent research into everyday practice.
LC Classification Number
RC516
Descrizione dell'oggetto fatta dal venditore
Informazioni su questo venditore
thebooklook
100% di Feedback positivi•10 mila oggetti venduti
Registrato come venditore privatoPertanto non si applicano i diritti dei consumatori derivanti dalla normativa europea. La Garanzia cliente eBay è comunque applicabile alla maggior parte degli acquisti. Scopri di piùScopri di più
Feedback sul venditore (2.966)
- k***r (230)- Feedback lasciato dall'acquirente.Ultimi 6 mesiAcquisto verificatoThanks so much exactly as described. Fast shipping, packaged really well as it had far to travel. The price was fair. Great communication with the seller. Will definitely purchase from this honest seller again. An A+++++ seller! Thanks again from one very happy buyer!Set 2 PUR 4-in-1 Correcting Primer Energize & Rescue - Prep & Perfect 1 oz NEW (N° 167011420706)
- e***s (40)- Feedback lasciato dall'acquirente.Ultimi 6 mesiAcquisto verificatoFast shipping. Packaged well. Good communication with seller. Answered quickly with my concerns in the description. Happy with products. Would recommend seller and will shop again.VINTAGE RARE NOS/IOB JUNKUNC BROS./AMERICAN LOCK CO./USA PADLOCK w/2 KEYS (N° 135484424818)
- *****- Feedback lasciato dall'acquirente.Mese scorsoAcquisto verificatoItem as described, great packaging, excellent communication, great seller!